A Study to Evaluate Safety and Efficacy of ASP015K in Patients With Rheumatoid Arthritis (RA) Who Had an Inadequate Response to DMARDs

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2014
The objective of this study was to verify the superiority of ASP015K alone or in combination with disease-modifying antirheumatic drugs (DMARDs) over placebo in terms of efficacy in participants with rheumatoid arthritis (RA) who had an inadequate response to DMARDs
Epistemonikos ID: d0d372a4049a8dab4f5f53ab7739e8a864903a10
First added on: Mar 23, 2022